0.97

0.72% 0.003

Bio Path Holdings Inc (BPTH)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Bio Path Holdings Inc stock is traded at $0.97, with a volume of 15,275. It is up +0.72% in the last 24 hours and up +12.51% over the past month. Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.

Previous Close:

$0.973

Open:

$0.99

24h Volume:

15,275

Relative Volume:

0.01

Market Cap:

$3.61M

Revenue:

Net Income/Loss:

$-16.08M

P/E Ratio:

-0.4389

EPS:

-2.21

Net Cash Flow:

$-11.54M

1W Performance:

-7.55%

1M Performance:

+12.51%

6M Performance:

-62.45%

1Y Performance:

-92.15%

1-Day Range:

$0.97

$0.9994

1-Week Range:

$0.90

$1.04

52-Week Range:

$0.846

$13.69

Bio Path Holdings Inc Stock (BPTH) Company Profile

Name

Bio Path Holdings Inc

Sector

Healthcare (1181)

Industry

Biotechnology (680)

Phone

(832) 742-1357

Address

4710 BELLAIRE BOULEVARD, BELLAIRE, TX

Employee

Twitter

Next Earnings Date

2024-11-13

Latest SEC Filings

BPTH's Discussions on Twitter

Bio Path Holdings Inc Stock (BPTH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-11-21	Initiated	ROTH Capital	Buy
Nov-13-17	Reiterated	H.C. Wainwright	Buy
Aug-10-16	Reiterated	Maxim Group	Buy
Apr-18-16	Initiated	Rodman & Renshaw	Buy
Jun-02-14	Resumed	Maxim Group	Buy
May-09-14	Initiated	Maxim Group	Buy

View All

Bio Path Holdings Inc Stock (BPTH) Latest News

Oct 31, 2024

Bio-Path (NASDAQ:BPTH) Now Covered by Analysts at StockNews.com - Defense World

Oct 31, 2024

Oct 30, 2024

T-cell Malignancies Clinical Trial Pipeline Insights Featuring 70+ Companies | DelveInsight - The Malaysian Reserve

Oct 30, 2024

Oct 29, 2024

Antisense Oligonucleotide Therapeutics Market Poised for Significant Growth, Projected to Reach $64.64 Bill... - WhaTech

Oct 29, 2024

Oct 27, 2024

RNA Interference Therapy Competitive Landscape Report 2024 (Updated) - openPR

Oct 27, 2024

Oct 23, 2024

Bio-Path (NASDAQ:BPTH) Earns Sell Rating from Analysts at StockNews.com - Defense World

Oct 23, 2024

Oct 21, 2024

RNA-based Therapeutics Market Latest Trends Analysis Report 2024 - InsightAce Analytic

Oct 21, 2024

Oct 18, 2024

siRNA Therapeutics Market Set for Explosive Growth, Projected to Reach $48.46 Billion by 2031 - WhaTech

Oct 18, 2024

Oct 16, 2024

80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight - 新浪香港

Oct 16, 2024

Oct 15, 2024

siRNA Therapeutics Market Set for Explosive Growth, Expected to Hit $48.46 Billion by 2031 As Revealed In N... - WhaTech

Oct 15, 2024

Thyroid Cancer Drug Market to Exhibit a Remarkable CAGR of 17.2% - openPR

Oct 15, 2024

Oct 14, 2024

Chronic Myeloid Leukemia (CML) Treatment Market Report Analysis, Research Studies |Novartis AG, Bristol-Myers Squibb, Te – IndiaPolitics.com - IndiaPolitics.com

Oct 14, 2024

Antisense Oligonucleotide (ASO) Therapeutics Market Size, Share, and Future Growth Analysis (2024-2032) - News in Assen

Oct 14, 2024

Antisense and RNAi Therapeutics Market Growth, Share, and Industry Forecast (2024-2032) - News in Assen

Oct 14, 2024

Oct 11, 2024

New World Solutions (CSE: NEWS) (OTC: REGRF) Appoints Capital Markets Veteran Martin Tremblay to Board of Directors - Wall Street Reporter

Oct 11, 2024

Analytical Overview: Bio-Path Holdings Inc (BPTH)’s Ratios Tell a Financial Story - The Dwinnex

Oct 11, 2024

Bio-Path Holdings Raises $4M Through Private Placement - TipRanks

Oct 11, 2024

Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - The Manila Times

Oct 11, 2024

Oct 10, 2024

Why this investor is skeptical about Tesla's robotaxi event - Yahoo Finance UK

Oct 10, 2024

Portfolio manager sees 'no landing' for US economy - Yahoo Finance UK

Oct 10, 2024

Russia to raise foreign company 'exit tax' to 35% from 15%, business daily reports - Yahoo Finance UK

Oct 10, 2024

Delta eyes Election Day travel pullback as profits climb - Yahoo Finance UK

Oct 10, 2024

Orient Green Power Shares Surge 7%, Outperform Sector Despite 'Strong Sell' Rating - Yahoo Finance UK

Oct 10, 2024

Prepare Yourself for Liftoff: Bio-Path Holdings Inc (BPTH) - SETE News

Oct 10, 2024

Dubai's DP World to use Hong Kong supply chain provider to connect China with the world - Yahoo Finance UK

Oct 10, 2024

Hungary central banker flags likely pause in rate cuts after forint falls - Yahoo Finance UK

Oct 10, 2024

Antisense Oligonucleotides Market Latest Sales Figure Signals More Opportunities Ahead - Elektrotransports.lv

Oct 10, 2024

Brookfield wins round Tritax Eurobox in £1.1bn tie-up - Yahoo Finance UK

Oct 10, 2024

London landlord GPE benefits from better investment conditions - Yahoo Finance UK

Oct 10, 2024

Oct 09, 2024